The long-term combination of azathioprine/mercaptopurine and anti-TNF therapy is best avoided in young people because of the risk of hepatosplenic T-cell lymphoma [EL4, RG D]. Infliximab (Remicade®) and adalimumab (Humira®) are IgG1 anti-TNF monoclonal antibodies with potent anti-...